These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiproliferative effects of mitoxantrone in ADR-sensitive and ADR-resistant P388 leukemia cells enhanced by vitamin K3. Parekh H, Chavan S, Chitnis M. Tumori; 1991 Dec 31; 77(6):484-90. PubMed ID: 1803714 [Abstract] [Full Text] [Related]
5. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Parekh H, Chitnis M. Sel Cancer Ther; 1990 Dec 31; 6(2):93-102. PubMed ID: 2367755 [Abstract] [Full Text] [Related]
6. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone. Chitnis MP, Kamath NS. Oncology; 1987 Dec 31; 44(1):47-50. PubMed ID: 3561929 [Abstract] [Full Text] [Related]
8. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C). Juvekar AS, Chitnis MP. Neoplasma; 1991 Dec 31; 38(2):207-11. PubMed ID: 2041579 [Abstract] [Full Text] [Related]
9. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells. Parekh H, Chavan S, Chitnis M. Anticancer Drugs; 1991 Apr 31; 2(2):159-68. PubMed ID: 1683589 [Abstract] [Full Text] [Related]
10. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Parekh HK, Mansuri-Torshizi H, Srivastava TS, Chitnis MP. Cancer Lett; 1992 Jan 10; 61(2):147-56. PubMed ID: 1730138 [Abstract] [Full Text] [Related]
12. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia. Kamath NS, Chitnis MP. Oncology; 1990 Jan 10; 47(2):166-9. PubMed ID: 2314829 [Abstract] [Full Text] [Related]
13. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells. Adwankar MK, Chitnis MP. Neoplasma; 1990 Jan 10; 37(1):31-6. PubMed ID: 2320178 [Abstract] [Full Text] [Related]
15. Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine. Parekh HK, Advani SH, Chitnis MP. Neoplasma; 1990 Jan 10; 37(6):717-25. PubMed ID: 2274089 [Abstract] [Full Text] [Related]
16. Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II. Deffie AM, McPherson JP, Gupta RS, Hedley DW, Goldenberg GJ. Biochem Cell Biol; 1992 May 10; 70(5):354-64. PubMed ID: 1353968 [Abstract] [Full Text] [Related]
17. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin. Chandrasekaran B, Dimling J, Capizzi RL. Cancer Treat Rep; 1987 Feb 10; 71(2):195-6. PubMed ID: 2948640 [Abstract] [Full Text] [Related]
18. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R, Reiter W, Krishan A. J Natl Cancer Inst; 1982 Jun 10; 68(6):1027-32. PubMed ID: 6953267 [Abstract] [Full Text] [Related]
19. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180. Pradhan SG, Chitnis MP, Basrur VS, Tantri SK. Eur J Cancer Clin Oncol; 1987 Apr 10; 23(4):437-42. PubMed ID: 3609108 [Abstract] [Full Text] [Related]
20. Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine. Viladkar A, Chitnis M. Cancer Biother; 1993 Apr 10; 8(1):77-85. PubMed ID: 7812352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]